Endra Life Sciences Inc Expected To Post A Loss Of 55 Cents A Share: Earnings Preview

ENDRA Life Sciences

12/08/2023 03:07

* ENDRA Life Sciences Inc  NDRA.OQ   NDRA.O  is expected
to show
no change in quarterly revenue when it reports  results on
August 14. 
    * 
    * ​Refinitiv's mean analyst estimate for ENDRA Life Sciences
Inc
is for a loss of 55 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for ENDRA Life
Sciences Inc is $20​, above​ its last closing price of $1.30.
​​​

This summary was machine generated August 12 at 02:07 GMT.  All
figures in US dollars  unless otherwise stated